GLP-1 modulator (Vivia Biotech)

N/A

Report date: 2026/05/12 20:00:17
NME

Base Information

Drug NameGLP-1 modulator (Vivia Biotech)
Drug Alias NameVivia-011
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVivia Biotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVivia Biotech
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A